MedPath
FDA Approval

Carbidopa and Levodopa

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 25, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Carbidopa(50 mg in 1 1)
Levodopa(200 mg in 1 1)

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carbidopa and Levodopa

Product Details

NDC Product Code
0378-0094
Application Number
ANDA075091
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 25, 2022
CarbidopaActive
Code: MNX7R8C5VOClass: ACTIMQuantity: 50 mg in 1 1
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQKClass: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OHClass: IACT
HYPROMELLOSE 2208 (4000 MPA.S)Inactive
Code: 39J80LT57TClass: IACT
LevodopaActive
Code: 46627O600JClass: ACTIBQuantity: 200 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Carbidopa and Levodopa

Product Details

NDC Product Code
0378-0088
Application Number
ANDA075091
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 25, 2022
CarbidopaActive
Code: MNX7R8C5VOClass: ACTIMQuantity: 25 mg in 1 1
LevodopaActive
Code: 46627O600JClass: ACTIBQuantity: 100 mg in 1 1
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OHClass: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQKClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYPROMELLOSE 2208 (4000 MPA.S)Inactive
Code: 39J80LT57TClass: IACT
© Copyright 2025. All Rights Reserved by MedPath